New Olympus President speaks on past acquisition deals

New Olympus President speaks on past acquisition deals

TOKYO, Japan - New Olympus Corp. President Shuichi Takayama speaks at a news conference in Tokyo on Oct. 27, 2011, a day after replacing Tsuyoshi Kikukawa as president of the camera and medical equipment maker. During the press conference, Takayama defended the company's past handling of acquisitions as legal and justifiable.

  • Product Code
  • ILEA001163859
  • Registered date
  • 2011/10/27 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2011 Kyodo News
  • Media size
  • 1303 × 1740 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 383.74(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    New Coronavirus

    New Coronavirus

    Japan's Health, Labor and Welfare Minister Katsunobu Kato speaks at a press conference in Tokyo on Feb. 5, 2020, following the detection of new coronavirus infections among people on luxury cruise ship Diamond Princess which returned to Yokohama on Feb. 3 after a 15-day in East and Southeast Asia voyage. (Kyodo) ==Kyodo
      Avigan could be formally approved as Ebola drug early 2015

      Avigan could be formally approved as Ebola drug early 2015

      TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.
        Osaka hospital succeeds in novel heart valve transplant

        Osaka hospital succeeds in novel heart valve transplant

        OSAKA, Japan - Osaka University professor Yoshiki Sawa (L) speaks at a press conference in Suita, Osaka Prefecture, on Oct. 27, 2014, about the first successful transplant surgery in Japan to replace a heart valve with a decelluraized one from a deceased donor. The 35-year-old patient (R) underwent the surgery at the Osaka University Hospital on Oct. 16 and has recovered steadily.
          Research to start on blood tests to detect 13 cancer types

          Research to start on blood tests to detect 13 cancer types

          TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
            Novartis management replaced

            Novartis management replaced

            TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
              Novartis management replaced

              Novartis management replaced

              TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                Novartis management replaced

                Novartis management replaced

                TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                  Takeda chief apologizes over data misuse in drug ad

                  Takeda chief apologizes over data misuse in drug ad

                  TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
                    Takeda chief apologizes over data misuse in drug ad

                    Takeda chief apologizes over data misuse in drug ad

                    TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
                      Ghostwriter for well-known Japanese composer

                      Ghostwriter for well-known Japanese composer

                      TOKYO, Japan - Takashi Niigaki, a music lecturer, speaks at a press conference at a Tokyo hotel on Feb. 6, 2014, the day after confessing that he has worked as a ghostwriter for Mamoru Samuragochi, a well-known Japanese composer, for nearly 20 years. At the press conference, Niigaki cast doubt over the composer's claim that he cannot hear.